InTrack Investment Management Inc increased its stake in Danaher Co. (NYSE:DHR - Free Report) by 47.5% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 9,969 shares of the conglomerate's stock after acquiring an additional 3,209 shares during the period. Danaher makes up about 1.6% of InTrack Investment Management Inc's holdings, making the stock its 14th largest holding. InTrack Investment Management Inc's holdings in Danaher were worth $2,369,000 as of its most recent filing with the Securities and Exchange Commission.
Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Decker Retirement Planning Inc. purchased a new stake in shares of Danaher in the 4th quarter valued at approximately $31,000. Teachers Insurance & Annuity Association of America purchased a new position in Danaher in the third quarter valued at $39,000. MidAtlantic Capital Management Inc. acquired a new stake in Danaher in the third quarter valued at $40,000. FSA Wealth Management LLC purchased a new stake in Danaher during the 3rd quarter worth about $50,000. Finally, Darwin Wealth Management LLC acquired a new position in shares of Danaher during the 3rd quarter worth about $55,000. 79.05% of the stock is currently owned by hedge funds and other institutional investors.
Danaher Stock Performance
NYSE DHR traded down $3.49 on Friday, hitting $238.41. 3,044,734 shares of the company's stock were exchanged, compared to its average volume of 2,640,177. The firm has a market cap of $172.20 billion, a price-to-earnings ratio of 45.50, a P/E/G ratio of 4.23 and a beta of 0.83. The firm's 50-day moving average price is $234.85 and its two-hundred day moving average price is $253.42. Danaher Co. has a fifty-two week low of $222.53 and a fifty-two week high of $281.70. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.37 and a quick ratio of 1.01.
Danaher (NYSE:DHR - Get Free Report) last announced its quarterly earnings data on Tuesday, October 22nd. The conglomerate reported $1.71 earnings per share for the quarter, topping analysts' consensus estimates of $1.57 by $0.14. Danaher had a return on equity of 10.62% and a net margin of 16.39%. The firm had revenue of $5.80 billion for the quarter, compared to analyst estimates of $5.59 billion. During the same quarter in the prior year, the company posted $2.02 earnings per share. Danaher's quarterly revenue was up 3.1% on a year-over-year basis. On average, research analysts expect that Danaher Co. will post 7.49 EPS for the current year.
Danaher Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Friday, January 31st. Investors of record on Friday, December 27th will be issued a dividend of $0.27 per share. This represents a $1.08 dividend on an annualized basis and a yield of 0.45%. The ex-dividend date of this dividend is Friday, December 27th. Danaher's dividend payout ratio is currently 20.61%.
Wall Street Analysts Forecast Growth
DHR has been the subject of several recent analyst reports. Scotiabank assumed coverage on Danaher in a research note on Monday, December 23rd. They set a "sector perform" rating and a $265.00 target price for the company. Guggenheim started coverage on shares of Danaher in a research report on Thursday, December 19th. They set a "buy" rating and a $275.00 price objective for the company. TD Cowen increased their target price on shares of Danaher from $310.00 to $315.00 and gave the company a "buy" rating in a research report on Wednesday, October 23rd. Citigroup reduced their price target on shares of Danaher from $305.00 to $285.00 and set a "buy" rating for the company in a research report on Monday, January 6th. Finally, Stifel Nicolaus raised their price objective on Danaher from $250.00 to $265.00 and gave the stock a "hold" rating in a report on Wednesday, October 23rd. Six analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average target price of $286.80.
Check Out Our Latest Report on Danaher
About Danaher
(
Free Report)
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.
Further Reading
Before you consider Danaher, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Danaher wasn't on the list.
While Danaher currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
